In the latest session, Enviva Inc. (NYSE: EVA) closed at $31.00 up 1.91% from its previous closing price of $30.42. In other words, the price has increased by $+0.58 from its previous closing price. On the day, 748711 shares were traded. EVA stock price reached its highest trading level at $31.55 during the session, while it also had its lowest trading level at $29.75.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Ratios:
For a deeper understanding of Enviva Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.80. In the meantime, Its Debt-to-Equity ratio is 4.76 whereas as Long-Term Debt/Eq ratio is at 4.70.
Upgrades & Downgrades
On October 14, 2022, Citigroup Upgraded its rating to Buy which previously was Neutral and also lowered its target price recommendation from $79 to $62.
Raymond James Upgraded its Mkt Perform to Outperform on September 15, 2022, while the target price for the stock was maintained at $80.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 05 when Kravtsova Yana sold 476 shares for $60.00 per share. The transaction valued at 28,560 led to the insider holds 89,985 shares of the business.
UBBEN JEFFREY W bought 200,000 shares of EVA for $11,000,000 on Dec 02. The Director now owns 5,742,439 shares after completing the transaction at $55.00 per share. On Dec 02, another insider, Keppler John K., who serves as the Former Chairman and CEO of the company, sold 200,000 shares for $55.00 each. As a result, the insider received 11,000,000 and left with 773,572 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.01 while its Price-to-Book (P/B) ratio in mrq is 6.20.
Stock Price History:
Over the past 52 weeks, EVA has reached a high of $91.06, while it has fallen to a 52-week low of $29.32. The 50-Day Moving Average of the stock is 43.74, while the 200-Day Moving Average is calculated to be 58.24.
Shares Statistics:
For the past three months, EVA has traded an average of 564.24K shares per day and 1M over the past ten days. A total of 66.87M shares are outstanding, with a floating share count of 35.99M. Insiders hold about 3.60% of the company’s shares, while institutions hold 83.70% stake in the company. Shares short for EVA as of Jan 12, 2023 were 6.05M with a Short Ratio of 5.48M, compared to 5.8M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 9.03% and a Short% of Float of 19.54%.
Dividends & Splits
According to the company, the forward annual dividend rate for EVA is 3.62, from 3.11 in the trailing year. Against a Trailing Annual Dividend Yield of 10.21%, it implies a Forward Annual Dividend Yield of 7.57%. The stock’s 5-year Average Dividend Yield is 6.87.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.57 for the current quarter, with a high estimate of $0.71 and a low estimate of $0.41, while EPS last year was -$1.46. The consensus estimate for the next quarter is -$0.12, with high estimates of $0.07 and low estimates of -$0.31.
Analysts are recommending an EPS of between $0.25 and -$0.95 for the fiscal current year, implying an average EPS of -$0.21. EPS for the following year is $0.77, with 3 analysts recommending between $0.89 and $0.59.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $422.3M this quarter.It ranges from a high estimate of $471.5M to a low estimate of $341.7M. As of the current estimate, Enviva Inc.’s year-ago sales were $278.19M, an estimated increase of 51.80% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $332.06M, an increase of 42.50% less than the figure of $51.80% in the same quarter last year. There is a high estimate of $362.13M for the next quarter, whereas the lowest estimate is $302M.
A total of 5 analysts have provided revenue estimates for EVA’s current fiscal year. The highest revenue estimate was $1.33B, while the lowest revenue estimate was $1.2B, resulting in an average revenue estimate of $1.28B. In the same quarter a year ago, actual revenue was $1.04B, up 22.60% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $1.6B in the next fiscal year. The high estimate is $1.76B and the low estimate is $1.42B. The average revenue growth estimate for next year is up 25.10% from the average revenue estimate for this year.
